← Open Payments lookup

JENNIFER ARMSTRONG: Open Payments

NPI 1952133506 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,721 in 184 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,866 · 2025 $4,721

Food & beverage: $4,721
CompanyPaymentsAmount
ABBVIE INC.24$803
E.R. Squibb & Sons, L.L.C.15$621
Alkermes, Inc.18$528
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$521
Supernus Pharmaceuticals, Inc.25$514
Tris Pharma Inc10$300
Teva Pharmaceuticals USA, Inc.22$235
Vanda Pharmaceuticals Inc.15$207
Neurocrine BioSciences, Inc.7$205
Luye Pharma (USA) Ltd.5$202

Products named: VRAYLAR, COBENFY, CAPLYTA, Qelbree, ARISTADA, FANAPT, INGREZZA, ERZOFRI EXTENDED-RELEASE.

Industry payments across MO — which companies pay providers there.